APP and Alzheimer disease: Santamaria et al. (2021) recently reported intranasal administration of secretome collected from MSCs exposed in vitro to AD mouse brain homogenates (MSCCS) induced persistent memory recovery, with dramatic reduction in amyloid plaque load and reactive gliosis in APP/PS1 AD mice model.